Patricia Bobzin serves as a Senior Director at Medpace, where she leverages her extensive expertise in clinical research and medical devices to drive the successful execution of large-scale global clinical trials. With a robust portfolio overseeing $67 million in sponsor engagements, Patricia excels in strategic...
Patricia Bobzin serves as a Senior Director at Medpace, where she leverages her extensive expertise in clinical research and medical devices to drive the successful execution of large-scale global clinical trials. With a robust portfolio overseeing $67 million in sponsor engagements, Patricia excels in strategic leadership, guiding a dedicated team of five clinical trial managers (CTMs) and ten additional staff members. Her role encompasses the comprehensive management of diverse clinical trials, ensuring that each project aligns with the specific objectives of sponsors while adhering to rigorous industry standards.
Patricia's proficiency in program management and her deep understanding of ICH-GCP guidelines enable her to design clinical trials that not only meet regulatory requirements but also mitigate risks effectively. She collaborates closely with sponsors to define and execute tailored strategies that ensure the safety of participants and the integrity of data, all while maintaining targeted timelines. Her expertise in contract negotiation and protocol development further enhances her ability to navigate the complexities of clinical research, making her a valuable asset in the life sciences sector.
In addition to her operational responsibilities, Patricia is committed to fostering a culture of excellence and innovation within her team. She encourages continuous learning and professional development, ensuring that her staff remains at the forefront of industry advancements. Patricia's leadership not only drives successful trial outcomes but also contributes to the overall growth and reputation of Medpace as a leading contract research organization (CRO) in the medical device arena. Her unique blend of clinical strategy, global leadership, and hands-on experience positions her as a thought leader in the field, dedicated to advancing the future of medical research.
